Aldo Morra

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

Luana Calabrò, Aldo Morra, Ester Fonsatti et al. · The Lancet Oncology · 2013 · 353 citations

Surgical Oncology, Malignant Disease, Medicine +5

Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis

Massimiliano Calabrese, Nicola De Stefano, Matteo Atzori et al. · Archives of Neurology · 2007 · 304 citations · Full text

Plantar fascia anatomy and its relationship with <scp>A</scp>chilles tendon and paratenon

Carla Stecco, Marco Corradin, Veronica Macchi et al. · Journal of Anatomy · 2013 · 250 citations · Full text

Fascial Repair, Anatomy, Orthopedic Biomechanics +16

Cortical atrophy is relevant in multiple sclerosis at clinical onset

Massimiliano Calabrese, Matteo Atzori, Valentina Bernardi et al. · Journal of Neurology · 2007 · 237 citations

Neurodegenerative Diseases, Neurological Disorder, Medicine +10

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study

Luana Calabrò, Aldo Morra, Diana Giannarelli et al. · The Lancet Respiratory Medicine · 2018 · 210 citations

Tumoral Pathology, Medicine, Metronomic Therapy +4